07:05 AM EDT, 08/05/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Friday that its Chief Operating Officer, Matthew Korenberg, will leave the company.
The departure will be effective Oct. 31, unless Korenberg chooses to terminate his employment with the company before that.